© 2002 European Society of Cardiology
Tumor necrosis factor-
polymorphism in Turkish patients with dilated cardiomyopathy
a Faculty of Medicine, Department of Pediatrics, Division of Genetic Diseases, Hacettepe University Ankara, Turkey
b Hacettepe University, Faculty of Medicine, Department of Cardiology Ankara, Turkey
* Corresponding author. Kuveyt caddesi No. 9, 06540 Kavaklidere, Ankara, Turkey. Tel.: +90-312-4683013; fax: +90-312-4661906 E-mail address: mehmet@gen.hun.edu.tr lalet@bim.net.tr tacil@lycos.com enveratalar@hotmail.com alioto@superonline.com
Received May 14, 2002; Revised August 7, 2002; Accepted September 17, 2002
| The first 10% of the full text of this article appears below. |
| 1. Background |
|---|
Tumor necrosis factor-
(TNF-
) is a proinflammatory cytokine with pleiotropic biological effects. Numerous studies have indicated a role of TNF-
in the pathophysiology of congestive heart failure [1–4]. Since genetic polymorphisms in the TNF locus were known to be related to several autoimmune, infectious, and neoplastic diseases [5], the association between TNF-
gene polymorphism and dilated cardiomyopathy (DCM) was also studied [6–8]. However, the results obtained were contradictory. Studies done in patients with different ethnic origins yielded contrasting results [6,7].
| 2. Aims |
|---|
| 3. Methods |
|---|
3.1. Serum samples and analysis of the TNF-
gene polymorphisms3.2. Statistical analysis
| 4. Results |
|---|
| 5. Conclusion |
|---|
This article has been cited by other articles:
![]() |
G. Kitsios and E. Zintzaras Genetic Variation associated with Ischemic Heart Failure: A HuGE Review and Meta-Analysis Am. J. Epidemiol., September 15, 2007; 166(6): 619 - 633. [Abstract] [Full Text] [PDF] |
||||
